Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Healthcare companies declined as traders evaluated changes to vaccine rules. The US will drop universal recommendations for certain childhood vaccines, marking a significant shift in vaccine policy. Sanofi's Tzield type-1 diabetes drug is under FDA review for expansion to children as young as one year old. Novo Nordisk shares rose after its Wegovy weight-loss pill became widely available in the US, while Eli Lilly shares fell.

Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios